Author Archives: admin


What Is Stem Cell Treatment? | eHow

Browse Articles & Videos By Category

Bronwyn Timmons

Based in Colorado, Bronwyn Timmons has been writing professionally since 2009. Her work has appeared on a variety of websites, covering topics such as career and education planning, wedding planning, home improvement, crafts and gardening. Timmons is pursuing her bachelor's degree in mortuary science.

Stem cell research is on the rise, giving hope to patients and providing treatment for many diseases and disorders. While stem cell treatments are a fairly new science, they can have life-saving effects.

Stem cell treatments consist of removing healthy regenerative cells from the patient and transplanting them into the affected area. This treatment helps repair and reverse a variety of conditions and diseases.

Regenerative cells can be harvested from the patient's bone marrow, fat or peripheral blood. This is done to eliminate the risk of cell rejection in the patient.

Typically, four to six treatments are administered depending on how the condition reacts to the stem cell treatment. Treatments are given over a period of seven to 12 days.

Stem cell treatments are effective at treating autoimmune diseases, cerebral palsy, degenerative joint disease, multiple sclerosis, osteoarthritis, rheumatoid arthritis, spinal injuries and type 2 diabetes. It is thought that in the future, stem cell treatment can be used to treat Alzheimer's disease.

Stem cell therapy can reduce pain and discomfort; it can help patients suffering from arthritis regain mobility. In serious cases, such as cerebral palsy and multiple sclerosis, stem cell treatments can be life-saving.

Because stem cell treatment is a new science, little is known about its long term effects. According to Cell Medicine, no side effects have been reported by patients other than pain at the injection site.

Go here to see the original:
What Is Stem Cell Treatment? | eHow

Global Stem Cells, Inc., Bioheart, Inc., and Paul Perito Urology Announce Plans to Launch Stem Cell Clinical Trials …

Miami, FL (PRWEB) February 11, 2014

Global Stem Cells Group, Bioheart, Inc., and Paul Perito Urology announce plans to launch stem cell clinical trials for treatment of Erectile Dysfunction (ED).

Paul Perito, M.D. of Perito Urology in Coral Gables, Florida and the principal investigator of the trial study, titled, "An Open-label, Non-randomized, Single-center Study to Assess the Safety and Effects of Autologous Adipose-derived Stromal Cells Delivered into the Corpus Cavernosum in Patients with Erectile Dysfunction," aims to assess the safety and efficacy of stem cell implantation therapy in patients with ED.

The cell therapy in this study will be composed of stem cells derived from a patients own adipose (fat) tissue, harvested by syringe liposuction. The adipose stem cells will then be delivered into the corpus cavernosum of the penis.

Clinical trials will be held at Perito Urology, in cooperation with Global Stem Cells Group and Bioheart. Up to 20 patients will be enrolled.

Fort Myers Florida-based Emcyte Corporation, a leading provider of biotechnology products for platelet rich plasma and bone marrow concentrate grafting procedures, will be providing systems and kits to be used in the trial.

To learn more about Global Stem Cells Group's clinical trials, and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.

About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Read the original post:
Global Stem Cells, Inc., Bioheart, Inc., and Paul Perito Urology Announce Plans to Launch Stem Cell Clinical Trials ...

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Worth $2.2 Billion by 2017

(PRWEB) February 11, 2014

The report Autologous Cell Therapy (ACT) Market (2012 - 2017), would be the first global and exclusive report on ACT market. It also gives clear information about the complete industry, approved products and potential market size; it also identifies driving and restraining factors for the global ACT market with analysis of trends, opportunities and challenges. The market is segmented and revenue is forecasted on the basis of major regions such as USA, Europe and Rest of the World (ROW). Further, market is segmented and revenues are forecasted on the basis of potential application areas of ACT.

Browse ACT market research data tables/figures spread through 111 slides and in-depth TOC on Autologous Cell Therapy Market". http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html

Early buyers will receive 10% customization on this report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=837.

The global market for ACT is valued around $650 million by 2011 with a CAGR of 21%. Several products and technologies of ACT are in pipeline which is expected to hit the market during the forecast period, which will result in increased growth rate.

There is a wide market potential and favorable landscape for adoption across many geographical locations of the world. During the forecast period, these technologies are expected to revolutionize the area of bio-pharma and personalized medicine. High incidence and lack of effective treatment for several diseases will drive the ACT technology in developed and developing nations.

Investment activities, for the past five years are actively held in research and developments, attracting interests of cell therapy industry firms, medical centers and academic institutions. ACT potential can be demonstrated by mergers, collaborations, acquisitions and partnerships that happened actively between the ACT technology developing companies in past three years. Development of sophisticated automation devices for cell expansion and culture process for use in the treatment is one of the emerging trends of ACT market.

Autologous Stem Cell and Non-Stem Cell Based treatments in North America are rapidly emerging as a major treatment for various incurable diseases such as Myocardial infarction, ischemic heart failure and diabetes.

Browse Related Reports: Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 2017) http://www.marketsandmarkets.com/Market-Reports/transfection-technologies-market-895.html

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018 http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

Follow this link:
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Worth $2.2 Billion by 2017

New stem cell research removes reliance on human and …

A new study, published today in the journal Applied Materials & Interfaces, has found a new method for growing human embryonic stem cells, that doesn't rely on supporting human or animal cells.

Traditionally, these stem cells are cultivated with the help of proteins from animals, which rules out use in the treatment of humans. Growing stem cells on other human cells risks contamination with pathogens that could transmit diseases to patients.

The team of scientists led by the University of Surrey and in collaboration with Professor Peter Donovan at the University of California have developed a scaffold of carbon nanotubes upon which human stem cells can be grown into a variety of tissues. These new building blocks mimic the surface of the body's natural support cells and act as scaffolding for stem cells to grow on. Cells that have previously relied on external living cells can now be grown safely in the laboratory, paving the way for revolutionary steps in replacing tissue after injury or disease.

Dr Alan Dalton, senior lecturer from the Department of Physics at the University of Surrey said: "While carbon nanotubes have been used in the field of biomedicine for some time, their use in human stem cell research has not previously been explored successfully."

"Synthetic stem cell scaffolding has the potential to change the lives of thousands of people, suffering from diseases such as Parkinson's, diabetes and heart disease, as well as vision and hearing loss. It could lead to cheaper transplant treatments and could potentially one day allow us to produce whole human organs without the need for donors."

Story Source:

The above story is based on materials provided by University of Surrey. Note: Materials may be edited for content and length.

Read this article:
New stem cell research removes reliance on human and ...

Adult Stem Cell Breakthrough Will Transform Medicine …

Dr. Marc Darrow, M.D., J.D.

(CNSNews.com) A scientific breakthrough that enables researchers to create adult stem cells much faster and easier will radically transform the way medicine is practiced, predicts Dr. Marc Darrow,assistant clinical professor of medicine at the University of California/Los Angeles (UCLA) School of Medicine.

It will be the standard of care, said Darrow, who teaches regenerative techniques utilizing platelets and adult stem cells to medical residents at UCLA, and who has been using the same techniques to treat patients with joint, tendon, ligament and muscle injuries in his own LAclinic.

Darrow explained that in the past, creating stem cell lines was a very tedious procedure which required using a pipette to take nuclear material from one cell to put into another.

But an article published January 29th in the peer-reviewed journalNature describes a new technique for creating undifferentiatedadult stem cells by immersing blood cells in an acid bath for half an hour.

BiologistHaruko Obokata, a stem cell researcher from Japans RIKEN Center of Developmental Biology, then injected the acid-stressed, florescently-tagged blood cells into a mouse embryo, where they created entire organs including a beatingheart.

Haruko Obokata (RIKEN Center for Developmental Biology)

Its amazing. I would have never thought external stress could have this effect, said study co-author YoshikiSasai. (See STAP cells.pdf)

The generation of these cells is essentially Mother Natures way of responding to injury, added co-author Charles Vacanti, director of the Laboratory for Tissue Engineering and Regenerative Medicine at the Harvard-affiliated Brigham Womens Hospital.

Read more:
Adult Stem Cell Breakthrough Will Transform Medicine ...

Genome editing goes hi-fi: Technique in stem cells to …

13 hours ago Beating-heart cells derived from iPS cells are shown. A single DNA base-pair of the PRKAG2 gene was edited using the method developed by Drs. Miyaoka and Conklin. Credit: Luke Judge/Gladstone Institutes

Sometimes biology is cruel. Sometimes simply a one-letter change in the human genetic code is the difference between health and a deadly disease. But even though doctors and scientists have long studied disorders caused by these tiny changes, replicating them to study in human stem cells has proven challenging. But now, scientists at the Gladstone Institutes have found a way to efficiently edit the human genome one letter at a timenot only boosting researchers' ability to model human disease, but also paving the way for therapies that cure disease by fixing these so-called 'bugs' in a patient's genetic code.

Led by Gladstone Investigator Bruce Conklin, MD, the research team describes in the latest issue of Nature Methods how they have solved one of science and medicine's most pressing problems: how to efficiently and accurately capture rare genetic mutations that cause diseaseas well as how to fix them. This pioneering technique highlights the type of out-of-the-box thinking that is often critical for scientific success.

"Advances in human genetics have led to the discovery of hundreds of genetic changes linked to disease, but until now we've lacked an efficient means of studying them," explained Dr. Conklin. "To meet this challenge, we must have the capability to engineer the human genome, one letter at a time, with tools that are efficient, robust and accurate. And the method that we outline in our study does just that."

One of the major challenges preventing researchers from efficiently generating and studying these genetic diseases is that they can exist at frequencies as low as 1%, making the task of finding and studying them labor-intensive.

"For our method to work, we needed to find a way to efficiently identify a single mutation among hundreds of normal, healthy cells," explained Gladstone Research Scientist Yuichiro Miyaoka, PhD, the paper's lead author. "So we designed a special fluorescent probe that would distinguish the mutated sequence from the original sequences. We were then able to sort through both sets of sequences and detect mutant cellseven when they made up as little one in every thousand cells. This is a level of sensitivity more than one hundred times greater than traditional methods."

The team then applied these new methods to induced pluripotent stem cells, or iPS cells. These cells, derived from the skin cells of human patients, have the same genetic makeupincluding any potential disease-causing mutationsas the patient. In this case, the research team first used a highly advanced gene-editing technique called TALENs to introduce a specific mutation into the genome. Some gene-editing techniques, while effective at modifying the genetic code, involve the use of genetic markers that then leave a 'scar' on the newly edited genome. These scars can then affect subsequent generations of cells, complicating future analysis. Athough TALENs, and other similarly advanced tools, are able to make a clean, scarless single letter edits, these edits are very rare, so that new technique from the Conklin lab is needed.

"Our method provides a novel way to capture and amplify specific mutations that are normally exceedingly rare," said Dr. Conklin. "Our high-efficiency, high-fidelity method could very well be the basis for the next phase of human genetics research."

"Now that powerful gene-editing tools, such as TALENs, are readily available, the next step is to streamline their implementation into stem cell research," said Dirk Hockemeyer, PhD, assistant professor of molecular and cellular biology at the University of California, Berkeley, who was not involved in this study. "This process will be greatly facilitated by the method described by Dr. Conklin and colleagues."

"Some of the most devastating diseases we face are caused by the tiniest of genetic changes," added Dr. Conklin. "But we are hopeful that our technique, by treating the human genome like lines of computer code, could one day be used to reverse these harmful mutations, and essentially repair the damaged code."

Go here to read the rest:
Genome editing goes hi-fi: Technique in stem cells to ...

Genome editing goes hi-fi: Technique in stem cells to boost scientists' ability to study genetic disease

13 hours ago Beating-heart cells derived from iPS cells are shown. A single DNA base-pair of the PRKAG2 gene was edited using the method developed by Drs. Miyaoka and Conklin. Credit: Luke Judge/Gladstone Institutes

Sometimes biology is cruel. Sometimes simply a one-letter change in the human genetic code is the difference between health and a deadly disease. But even though doctors and scientists have long studied disorders caused by these tiny changes, replicating them to study in human stem cells has proven challenging. But now, scientists at the Gladstone Institutes have found a way to efficiently edit the human genome one letter at a timenot only boosting researchers' ability to model human disease, but also paving the way for therapies that cure disease by fixing these so-called 'bugs' in a patient's genetic code.

Led by Gladstone Investigator Bruce Conklin, MD, the research team describes in the latest issue of Nature Methods how they have solved one of science and medicine's most pressing problems: how to efficiently and accurately capture rare genetic mutations that cause diseaseas well as how to fix them. This pioneering technique highlights the type of out-of-the-box thinking that is often critical for scientific success.

"Advances in human genetics have led to the discovery of hundreds of genetic changes linked to disease, but until now we've lacked an efficient means of studying them," explained Dr. Conklin. "To meet this challenge, we must have the capability to engineer the human genome, one letter at a time, with tools that are efficient, robust and accurate. And the method that we outline in our study does just that."

One of the major challenges preventing researchers from efficiently generating and studying these genetic diseases is that they can exist at frequencies as low as 1%, making the task of finding and studying them labor-intensive.

"For our method to work, we needed to find a way to efficiently identify a single mutation among hundreds of normal, healthy cells," explained Gladstone Research Scientist Yuichiro Miyaoka, PhD, the paper's lead author. "So we designed a special fluorescent probe that would distinguish the mutated sequence from the original sequences. We were then able to sort through both sets of sequences and detect mutant cellseven when they made up as little one in every thousand cells. This is a level of sensitivity more than one hundred times greater than traditional methods."

The team then applied these new methods to induced pluripotent stem cells, or iPS cells. These cells, derived from the skin cells of human patients, have the same genetic makeupincluding any potential disease-causing mutationsas the patient. In this case, the research team first used a highly advanced gene-editing technique called TALENs to introduce a specific mutation into the genome. Some gene-editing techniques, while effective at modifying the genetic code, involve the use of genetic markers that then leave a 'scar' on the newly edited genome. These scars can then affect subsequent generations of cells, complicating future analysis. Athough TALENs, and other similarly advanced tools, are able to make a clean, scarless single letter edits, these edits are very rare, so that new technique from the Conklin lab is needed.

"Our method provides a novel way to capture and amplify specific mutations that are normally exceedingly rare," said Dr. Conklin. "Our high-efficiency, high-fidelity method could very well be the basis for the next phase of human genetics research."

"Now that powerful gene-editing tools, such as TALENs, are readily available, the next step is to streamline their implementation into stem cell research," said Dirk Hockemeyer, PhD, assistant professor of molecular and cellular biology at the University of California, Berkeley, who was not involved in this study. "This process will be greatly facilitated by the method described by Dr. Conklin and colleagues."

"Some of the most devastating diseases we face are caused by the tiniest of genetic changes," added Dr. Conklin. "But we are hopeful that our technique, by treating the human genome like lines of computer code, could one day be used to reverse these harmful mutations, and essentially repair the damaged code."

Here is the original post:
Genome editing goes hi-fi: Technique in stem cells to boost scientists' ability to study genetic disease

Local mom bounces back after life-threatening illness

Published: Sunday, February 9, 2014 at 4:30 a.m. Last Modified: Saturday, February 8, 2014 at 10:56 p.m.

An avid runner, tennis player and rollerblader, Massagee's journey began nearly 10 years ago, when she began to notice her body slowly change, and included an endless parade of doctors, chemptherapy and a risky stem cell transplant.

Over time, Massagee's muscles grew larger. That wasn't necessarily a bad thing for an athletic woman in her early 50s, but as people age they tend to lose, not gain, muscle mass. Then her muscles began to harden and tighten, causing her significant pain.

Her husband, Buddy, a Hendersonville attorney, declared one day that something just wasn't right. Massagee had become so muscular that some in her social circle silently wondered if she was taking steroids to bulk up. She looked more like a professional body builder than an active mother of five.

As her muscles continued to harden and tighten, physical activity became more and more difficult. Massagee sought medical treatment from at least a dozen doctors, including the best of the best at Duke University Medical Center in Durham. After batteries of tests over several years, not a single doctor could tell Massagee what was wrong. Some doctors later confided to her that they thought I was secretly taking steroids and lying about it.

When a brain scan showed that the muscles behind her eyes were much larger than they should have been, doctors realized she wasn't on steroids, but they still weren't any closer to figuring out what was wrong. Bouncing from doctor to doctor, test to test, began to take its toll on Massagee physically and emotionally.

What broke my heart the most was looking at the pain it was causing Buddy and the children, she recalled. The couple's children, Sarah, 32, Rachel, 28, Kelly, 26, Lucy, 24 and Ty, 22, weren't very open about it we didn't talk about it a lot, Massagee said. But I knew it was very, very difficult for them.

Eventually, she found it impossible to undertake the most rudimentary physical activity, let alone work as a CPA.

I couldn't stand to make dinner, she said. I'd stand to chop something and then I'd need to sit down on a stool. I couldn't walk two blocks without having to stop.

One day, Massagee found it impossible to lift her arms enough to put on a pair of earrings.

Continued here:
Local mom bounces back after life-threatening illness

Exclusive: The miracle cure – scientists turn human skin …

The demonstration that the technique, which was pioneered on mouse cells, also works on human skin cells raises the prospect of new treatments for incurable illnesses, from Parkinson's to heart disease, based on regenerating diseased organs in situ from a patient's own stem cells.

Although there is no intention to create human embryos from skin cells, scientists believe that it could, theoretically, be possible to do so given that entire mouse embryos have already been effectively created from the re-engineered blood cells of laboratory mice.

Creating the mouse embryos was the final proof the scientists needed to demonstrate that the stem cells were "pluripotent", and so capable of developing into any specialised tissue of an adult animal, including the "germ cells" that make sperm and eggs.

Pluripotent stem cells could usher in a new age of medicine based on regenerating diseased organs or tissues with injections of tissue material engineered from a patient's own skin or blood, which would pose few problems in terms of tissue rejection.

However, the technique also has the potential to be misused for cloning babies, although stem cell scientists believe there are formidable technical, legal and ethical obstacles that would make this effectively impossible.

A team of Japanese and American scientists converted human skin cells into stem cells using the same simple approach that had astonished scientists around the world last month when they announced that they had converted blood cells of mice into stem cells by bathing them in a weak solution of citric acid for 30 minutes.

The scientist who instigated the research programme more than a decade ago said that he now has overwhelming evidence that the same technique can be used to create embryonic-like stem cells from human skin cells.

Charles Vacanti, a tissue engineer at Brigham and Women's Hospital in Boston, Massachusetts, said that the same team of researchers has generated stem cells from human dermal fibroblasts skin cells which came from a commercial source of human tissues sold for research purposes.

"The process was very similar to the one we used on mouse cells, but we used human dermal fibroblasts that we purchased commercially," Dr Vacanti said. "I can confirm that stem cells were made when we treated these human cells. They do the same thing [as the mouse cells].

"They revert back to stem cells, and we believe the stem cells are not a contamination in the sample that we were inadvertently sent by the company, but that they are being made, although we still have to do the final tests to prove this," he added.

Read more:
Exclusive: The miracle cure - scientists turn human skin ...